Jun 16, 2026 07:01AM
Jun 16, 2026 07:01AM
Jun 9, 2026 07:01AM
Jun 9, 2026 07:01AM
Jun 3, 2026 07:01AM
Jun 1, 2026 07:02AM
Jun 1, 2026 07:01AM Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID
May 27, 2026 07:01AM
May 14, 2026 07:01AM
May 11, 2026 07:01AM
May 11, 2026 07:01AM
May 7, 2026 07:01AM
May 5, 2026 07:01AM
Apr 20, 2026 07:01AM Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care Summit
Apr 9, 2026 07:03AM
Apr 9, 2026 07:01AM
Apr 6, 2026 07:01AM
Mar 30, 2026 04:05PM
Mar 5, 2026 07:03AM
Mar 5, 2026 07:01AM
Mar 5, 2026 07:01AM Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer
Mar 2, 2026 04:10PM
Mar 2, 2026 04:01PM
Feb 24, 2026 07:01AM
Feb 4, 2026 07:09AM
Feb 3, 2026 07:01AM
Feb 3, 2026 07:01AM
Jan 22, 2026 07:01AM Invivyd partners with skier Lindsey Vonn for antibody education campaign
Jan 22, 2026 07:01AM
Jan 20, 2026 07:01AM
Jan 20, 2026 07:01AM
Jan 8, 2026 07:08AM
Jan 8, 2026 07:01AM
Dec 23, 2025 07:05AM
Dec 23, 2025 07:05AM Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
Dec 23, 2025 07:01AM
Dec 23, 2025 07:01AM
Nov 25, 2025 07:01AM
Nov 24, 2025 07:01AM
Nov 24, 2025 07:01AM
Nov 17, 2025 10:40PM
Nov 17, 2025 10:40PM Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants
Nov 17, 2025 04:01PM
Nov 17, 2025 04:01PM
Nov 6, 2025 07:01AM
Nov 3, 2025 04:01PM
Nov 3, 2025 06:46AM
Oct 28, 2025 07:01AM
Oct 6, 2025 07:01AM Invivyd receives FDA clearance for COVID antibody drug trials
Oct 6, 2025 07:01AM

323,577 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All